Consistent Scalable Functionalised Graphene Capacity
News Mar 05, 2015
Haydale Ltd., a technological leader in the development of functionalised graphenes to improve the mechanical performance of epoxy resin systems and Carbon Fibre reinforced plastics, has announced further significant investment in production capacity.
In December 2014, Haydale announced the delivery of two new Rotovac HD60 plasma reactors. These reactors are now both fully operational and provide Haydale increased processing capability and operational flexibility in functionalising graphenes and other nano materials. Consequently, Haydale has ordered a further three Rotovac HD60 units for delivery by the end of June 2015 of which two will be shipped to overseas locations as part of the strategic move to support worldwide demand for Haydale functionalised graphene materials.
Haydale has now taken delivery of an additional significantly larger reactor, the HD200, to fulfil anticipated increased customer orders following successful sampling and supply from the smaller units. This unit has now passed its factory acceptance test and has arrived four weeks earlier than expected. Commissioning has already commenced.
Ray Gibbs, CEO at Haydale, commented "At this stage in the development of the graphene industry, customers are looking for consistent quality of functionalised graphenes in kilograms, not initially tonnes, although volume will follow successful trialling. It is however crucial that the samples provided are capable of being repeated in larger commercial volumes and that is exactly what we can provide. We now have 3 HD60 plasma reactors in operation providing the required flexibility to process a variety of materials for different customers simultaneously. The arrival of the larger machine further increases our capability as the demand for volumes increases."
Nanoparticles show great promise as diagnostic tools and drug delivery agents. But until now, most nanoparticles had to be injected into the bloodstream because they weren’t absorbed well orally. Now, researchers have modified nanoparticles to improve their uptake in the gastrointestinal tract.